[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337602-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337602-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","altered-lipid-metabolism-as-a-predisposing-factor-for-liver-metastasis-in-masld","Altered lipid metabolism as a predisposing factor for liver metastasis in MASLD","","Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising as metabolic comorbidities such as obesity and type 2 diabetes expand. Steatotic liver becomes a metastasis hotspot in MASLD because altered lipid metabolism remodels the tissue microenvironment to support metastatic liver cancer growth. Tumors further worsen hepatic metabolic dysregulation by releasing extracellular vesicles and particles, while lipid changes reshape immune cell proliferation, differentiation, and function. The review explains mechanisms linking steatotic liver to an immunosuppressive, metastasis-prone niche and outlines lipid metabolism manipulation strategies for managing metastatic liver cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/altered-lipid-metabolism-as-a-predisposing-factor-for-liver-metastasis-in-masld/337602/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/altered-lipid-metabolism-as-a-predisposing-factor-for-liver-metastasis-in-masld/337602.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",15,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is altered lipid metabolism considered a key driver in MASLD-related liver metastasis?","Question",{"text":63,"@type":64},"Altered lipid metabolism remodels the tissue microenvironment, making it conducive to metastatic liver cancer growth. It also influences immune cell proliferation, differentiation, and functions, promoting immunosuppression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does MASLD relate to prior terminology such as NAFLD?",{"text":68,"@type":64},"MASLD was adopted to address limitations of earlier nomenclature, avoid stigmatizing wording, and include patients who may have lean NAFLD phenotypes under prior criteria.",{"name":70,"@type":61,"acceptedAnswer":71},"What role do extracellular vesicles and particles play in tumor progression in MASLD?",{"text":72,"@type":64},"Tumors release extracellular vesicles and particles into the liver, exacerbating dysregulated hepatic metabolism. This contributes to a metastasis-prone, immunosuppressive microenvironment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337602,1790146006,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Molecules and Cells Minireview  \nAltered lipid metabolism as a predisposing factor for liver metastasis in MASLD  \nSo Jung Kim 1 ,2 and Jeongeun Hyun 1 ,2 ,3 ,⁎  \n1 Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan 31116, Republic of Korea, 2Department of Nanobiomedical Science and BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan 31116, Republic of Korea, 3Mechanobiology Dental Medicine Research Center, College of Dentistry, Dankook University, Cheonan 31116, Republic of Korea  \n⁎Correspondence to: [j.hyun@dankook.ac.kr](j.hyun@dankook.ac.kr) (JH) [https://doi.org/10.1016/j.mocell.2024.100010](https://doi.org/10.1016/j.mocell.2024.100010)  \nABSTRACT  \nRecently, the incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing due to the high prevalence of metabolic conditions, such as obesity and type 2 diabetes mellitus. Steatotic liver is a hotspot for cancer metastasis in MASLD. Altered lipid metabolism, a hallmark of MASLD, remodels the tissue microenvironment, making it conducive to the growth of metastatic liver cancer. Tumors exacerbate the dysregulation of hepatic metabolism by releasing extracellular vesicles and particles into the liver. Altered lipid metabolism influences the proliferation, differentiation, and functions of immune cells, contributing to the formation of an immunosuppressive and metastasis-prone liver microenvironment in MASLD. This review discusses the mechanisms by which the steatotic liver promotes liver metastasis progression, focusing on its role in fostering an immunosuppressive microenvironment in MASLD. Furthermore, this review highlights lipid metabolism manipulation strategies for the therapeutic management of metastatic liver cancer.  \n© 2024 The Author(s) . Published by Elsevier Inc. on behalf of Korean Society for Molecular and Cellular Biology. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/l](http://creativecommons.org/l)icenses/by-nc-nd/4 .0/) .  \nKeywords: Immunosuppression, Lipid metabolism, Liver metastasis, Metabolic dysfunction-associated steatotic liver disease, Premetastatic niche  \nINTRODUCTION  \nMetabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is characterized by hepatic steatosis and the presence of at least 1 of the 5 cardiometabolic risk factors, including central or overall obesity, hypertension, pre-diabetes, hypertriglyceridemia, and low high-density lipoprotein ( De et al. , 2024) . MASLD was adopted based on the consensus among major liver associations to address the limitations inherent in previous nomenclatures. This terminology avoids stigmatizing the patients by eliminating the term “fatty” and provides a clearer understanding of the nature of the disease ( De et al. , 2024; Rinella et al. , 2023) . It also overcomes the constraints associated with the former term, NAFLD, which has stringent thresholds that may exclude patients from clinical trials and limit their treatment options. Moreover, the term “MASLD”broadens inclusivity by involving individuals with NAFLD who are lean with a normal body mass index, a subgroup often overlooked in the previous metabolic dysfunction-associated fatty liver disease criteria ( De et al. , 2024) . Therefore, in this  \nreview, we will use the term MASLD, even though it was referred to as NAFLD or metabolic dysfunction-associated fatty liver disease in the original studies.  \nMASLD encompasses a spectrum of chronic conditions ranging from steatosis to steatohepatitis, progressing toward cirrhosis, liver failure, and liver cancer (Rinella et al. , 2023) . Its increasing prevalence has made it the primary indication for liver transplantation and a vital etiological factor for primary liver cancer (Burra et al. , 2020) . Steatotic liver in MASLD serves as a fertile ground for the growth of liver metastatic tumor","cbCaibiUDnYw0RTA","https://ap.wps.com/l/cbCaibiUDnYw0RTA","pdf",4665723,12,"English","# Abstract\n# Introduction\n## MASLD terminology and disease spectrum\n## Steatotic liver as a predisposing microenvironment for metastasis\n## Extracellular vesicles/particles and immune impairment","[{\"question\":\"Why is altered lipid metabolism considered a key driver in MASLD-related liver metastasis?\",\"answer\":\"Altered lipid metabolism remodels the tissue microenvironment, making it conducive to metastatic liver cancer growth. It also influences immune cell proliferation, differentiation, and functions, promoting immunosuppression.\"},{\"question\":\"How does MASLD relate to prior terminology such as NAFLD?\",\"answer\":\"MASLD was adopted to address limitations of earlier nomenclature, avoid stigmatizing wording, and include patients who may have lean NAFLD phenotypes under prior criteria.\"},{\"question\":\"What role do extracellular vesicles and particles play in tumor progression in MASLD?\",\"answer\":\"Tumors release extracellular vesicles and particles into the liver, exacerbating dysregulated hepatic metabolism. This contributes to a metastasis-prone, immunosuppressive microenvironment.\"}]","Altered lipid metabolism as a predisposing factor for liver metastasis in MASLD | PDF",1790019747,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe0d2cf878a8fc963523960a95367381.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f32a6baf0db7fb034d0c67c3f2be1742.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95f001de347f16afea51b7b957f7041c.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b69bd204c73c638624702112762c519b.webp",980,1306]